Cardinal Health, Inc. (NYSE:CAH) Stock Position Lifted by Mather Group LLC.

Mather Group LLC. grew its position in Cardinal Health, Inc. (NYSE:CAH) by 20.7% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,685 shares of the company’s stock after acquiring an additional 1,146 shares during the quarter. Mather Group LLC.’s holdings in Cardinal Health were worth $657,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Clearstead Trust LLC bought a new stake in Cardinal Health during the fourth quarter valued at $25,000. Raleigh Capital Management Inc. raised its stake in Cardinal Health by 4,466.7% during the fourth quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock worth $28,000 after acquiring an additional 268 shares during the period. YHB Investment Advisors Inc. acquired a new stake in Cardinal Health during the first quarter worth about $32,000. LRI Investments LLC acquired a new position in Cardinal Health in the first quarter valued at approximately $32,000. Finally, Palisade Asset Management LLC bought a new position in shares of Cardinal Health during the first quarter valued at approximately $34,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

CAH has been the subject of a number of analyst reports. Citigroup reduced their price objective on Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a research report on Friday, July 19th. Wells Fargo & Company reduced their price target on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a report on Monday, April 29th. Argus dropped their price objective on shares of Cardinal Health from $120.00 to $115.00 and set a “buy” rating on the stock in a report on Wednesday, May 15th. Evercore ISI reduced their target price on shares of Cardinal Health from $115.00 to $105.00 and set an “in-line” rating for the company in a research note on Tuesday, July 9th. Finally, Robert W. Baird raised their price target on shares of Cardinal Health from $129.00 to $130.00 and gave the company an “outperform” rating in a research note on Tuesday, July 9th. One analyst has rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $109.67.

Cardinal Health Stock Performance

Shares of CAH stock traded up $1.16 during mid-day trading on Tuesday, hitting $99.52. 1,782,399 shares of the stock traded hands, compared to its average volume of 2,150,915. Cardinal Health, Inc. has a twelve month low of $85.11 and a twelve month high of $116.04. The company’s 50-day simple moving average is $98.57 and its 200-day simple moving average is $103.32. The firm has a market cap of $24.24 billion, a price-to-earnings ratio of 44.23, a price-to-earnings-growth ratio of 1.14 and a beta of 0.61.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.